BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25212528)

  • 1. Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer.
    Speicher PJ; Wang X; Englum BR; Ganapathi AM; Yerokun B; Hartwig MG; D'Amico TA; Berry MF
    Dis Esophagus; 2015; 28(8):788-96. PubMed ID: 25212528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.
    Raman V; Jawitz OK; Voigt SL; Yang CJ; D'Amico TA; Harpole DH
    J Surg Res; 2020 May; 249():82-90. PubMed ID: 31926400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction therapy for locally advanced distal esophageal adenocarcinoma: Is radiation Always necessary?
    Liou DZ; Backhus LM; Lui NS; Shrager JB; Berry MF
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2697-2707. PubMed ID: 29530567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.
    Samson P; Robinson C; Bradley J; Lockhart AC; Puri V; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
    J Thorac Oncol; 2016 Dec; 11(12):2227-2237. PubMed ID: 27544058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Treatment of T1N0 Esophageal Cancer.
    Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
    Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
    Javidfar J; Speicher PJ; Hartwig MG; D'Amico TA; Berry MF
    Ann Thorac Surg; 2016 Mar; 101(3):1060-7. PubMed ID: 26576752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging.
    Taylor MD; LaPar DJ; Davis JP; Isbell JM; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Jul; 96(1):225-30: discussion 230-1. PubMed ID: 23618518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.
    Haque W; Verma V; Bernicker E; Butler EB; Teh BS
    Acta Oncol; 2018 Jun; 57(6):782-789. PubMed ID: 29188742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma.
    Wong LY; Liou DZ; Vitzthum LK; Backhus LM; Lui NS; Chang D; Shrager JB; Berry MF
    Ann Surg Oncol; 2023 Apr; 30(4):2212-2223. PubMed ID: 36572807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival.
    Samson P; Puri V; Lockhart AC; Robinson C; Broderick S; Patterson GA; Meyers B; Crabtree T
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1725-1735. PubMed ID: 30054137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
    Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
    J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
    Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
    Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database.
    Mitzman B; Lutfi W; Wang CH; Krantz S; Howington JA; Kim KW
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):244-253. PubMed ID: 28823338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
    Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
    Speicher PJ; Ganapathi AM; Englum BR; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
    J Thorac Oncol; 2014 Aug; 9(8):1195-201. PubMed ID: 25157773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.